Cargando…
Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics
Bladder cancer is one of the most common urinary tract carcinomas in the world. Urine metabolomics is a promising approach for bladder cancer detection and marker discovery since urine is in direct contact with bladder epithelia cells; metabolites released from bladder cancer cells may be enriched i...
Autores principales: | Shao, Chi-Hung, Chen, Chien-Lun, Lin, Jia-You, Chen, Chao-Jung, Fu, Shu-Hsuan, Chen, Yi-Ting, Chang, Yu-Sun, Yu, Jau-Song, Tsui, Ke-Hung, Juo, Chiun-Gung, Wu, Kun-Pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503573/ https://www.ncbi.nlm.nih.gov/pubmed/28415579 http://dx.doi.org/10.18632/oncotarget.16393 |
Ejemplares similares
-
Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics
por: Lin, Jia-You, et al.
Publicado: (2021) -
Urinary Metabolomic Analysis of Prostate Cancer by UPLC-FTMS and UPLC-Ion Trap MS(n)
por: Chen, Chien-Lun, et al.
Publicado: (2023) -
iMet-Q: A User-Friendly Tool for Label-Free Metabolomics Quantitation Using Dynamic Peak-Width Determination
por: Chang, Hui-Yin, et al.
Publicado: (2016) -
Clinical outcome of primary small cell carcinoma of the urinary bladder
por: Hou, Chen-Pang, et al.
Publicado: (2013) -
Association between Bladder Outlet Obstruction and Bladder Cancer in Patients with Aging Male
por: Lin, Yu-Hsiang, et al.
Publicado: (2019)